Last week, the U.S. Food and Drug Administration (FDA) approved the gene drug Kymriah for certain types of cancer. However, Kymriah costs $475,000 for...
Canada’s securities regulators released a guidance document that explains their approach to ICOs and token sales. Here is what this notice means and what it doesn’t.
Blockchain theorist Melanie Swan discusses three recent developments in the blockchain economy, using classical economic principles to distinguish between hype and long-term structural change.
Lost in the headlines over the SEC’s recent report on cryptocurrency was important practical advice for both promoters of and participants in initial coin offerings (ICOs).
Digital currency practices have exploded in recent months, bringing to the forefront new regulations. This means VC investors looking to get a piece of...
It was only a matter of time before the U.S. Securities and Exchange Commission (SEC) moved in on the “Wild West” world of Initial Coin Offerings (ICOs).
